Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Inflammatory Bowel Diseases

  Free Subscription


Articles published in J Gastroenterol

Retrieve available abstracts of 25 articles:
HTML format
Text format



Single Articles


    April 2017
  1. SUZUKI Y, Motoya S, Hanai H, Hibi T, et al
    Erratum to: Four-year maintenance treatment with adalimumab in Japanese patients with moderately to severely active ulcerative colitis.
    J Gastroenterol. 2017 Apr 12. doi: 10.1007/s00535-017-1340.
    PubMed     Text format    


    March 2017
  2. HIBI T, Imai Y, Senoo A, Ohta K, et al
    Efficacy and safety of golimumab 52-week maintenance therapy in Japanese patients with moderate to severely active ulcerative colitis: a phase 3, double-blind, randomized, placebo-controlled study-(PURSUIT-J study).
    J Gastroenterol. 2017 Mar 21. doi: 10.1007/s00535-017-1326.
    PubMed     Text format     Abstract available


  3. SUZUKI Y, Motoya S, Hanai H, Hibi T, et al
    Four-year maintenance treatment with adalimumab in Japanese patients with moderately to severely active ulcerative colitis.
    J Gastroenterol. 2017 Mar 20. doi: 10.1007/s00535-017-1325.
    PubMed     Text format     Abstract available


    February 2017
  4. ARAKI M, Shinzaki S, Yamada T, Arimitsu S, et al
    Age at onset is associated with the seasonal pattern of onset and exacerbation in inflammatory bowel disease.
    J Gastroenterol. 2017 Feb 6. doi: 10.1007/s00535-017-1313.
    PubMed     Text format     Abstract available


    November 2016
  5. IBORRA M, Gisbert JP, Bosca-Watts MM, Lopez-Garcia A, et al
    Erratum to: Effectiveness of adalimumab for the treatment of ulcerative colitis in clinical practice: comparison between anti-tumour necrosis factor-naive and non-naive patients.
    J Gastroenterol. 2016.
    PubMed     Text format    


  6. CHAN HC, Ng SC
    Emerging biologics in inflammatory bowel disease.
    J Gastroenterol. 2016.
    PubMed     Text format     Abstract available


    October 2016
  7. NISHIDA A, Imaeda H, Ohno M, Inatomi O, et al
    Efficacy and safety of single fecal microbiota transplantation for Japanese patients with mild to moderately active ulcerative colitis.
    J Gastroenterol. 2016.
    PubMed     Text format     Abstract available


  8. IBORRA M, Perez-Gisbert J, Bosca-Watts MM, Lopez-Garcia A, et al
    Effectiveness of adalimumab for the treatment of ulcerative colitis in clinical practice: comparison between anti-tumour necrosis factor-naive and non-naive patients.
    J Gastroenterol. 2016.
    PubMed     Text format     Abstract available


    September 2016
  9. MARTELLI L, Olivera P, Roblin X, Attar A, et al
    Cost-effectiveness of drug monitoring of anti-TNF therapy in inflammatory bowel disease and rheumatoid arthritis: a systematic review.
    J Gastroenterol. 2016.
    PubMed     Text format     Abstract available


    July 2016
  10. UENO F, Nakayama Y, Hagiwara E, Kurimoto S, et al
    Impact of inflammatory bowel disease on Japanese patients' quality of life: results of a patient questionnaire survey.
    J Gastroenterol. 2016.
    PubMed     Text format     Abstract available


  11. KEDIA S, Rampal R, Paul J, Ahuja V, et al
    Gut microbiome diversity in acute infective and chronic inflammatory gastrointestinal diseases in North India.
    J Gastroenterol. 2016;51:660-71.
    PubMed     Text format     Abstract available


    June 2016
  12. IBOSHI Y, Nakamura K, Fukaura K, Iwasa T, et al
    Erratum to: "Increased IL-17A/IL-17F expression ratio represents the key mucosal T helper/regulatory cell-related gene signature paralleling disease activity in ulcerative colitis".
    J Gastroenterol. 2016.
    PubMed     Text format    


  13. MUSCI JO, Cornish JS, Dabritz J
    Utility of surrogate markers for the prediction of relapses in inflammatory bowel diseases.
    J Gastroenterol. 2016;51:531-47.
    PubMed     Text format     Abstract available


    May 2016
  14. IBOSHI Y, Nakamura K, Fukaura K, Iwasa T, et al
    Increased IL-17A/IL-17F expression ratio represents the key mucosal T helper/regulatory cell-related gene signature paralleling disease activity in ulcerative colitis.
    J Gastroenterol. 2016.
    PubMed     Text format     Abstract available


  15. SUGIMOTO S, Naganuma M, Kanai T
    Indole compounds may be promising medicines for ulcerative colitis.
    J Gastroenterol. 2016.
    PubMed     Text format     Abstract available


    April 2016
  16. KUWAHARA E, Murakami Y, Nakamura T, Inoue N, et al
    Factors associated with exacerbation of newly diagnosed mild ulcerative colitis based on a nationwide registry in Japan.
    J Gastroenterol. 2016.
    PubMed     Text format     Abstract available


  17. WILSON JC, Furlano RI, Jick SS, Meier CR, et al
    A population-based study examining the risk of malignancy in patients diagnosed with inflammatory bowel disease.
    J Gastroenterol. 2016.
    PubMed     Text format     Abstract available


    February 2016
  18. IKHTAIRE S, Shajib MS, Reinisch W, Khan WI, et al
    Fecal calprotectin: its scope and utility in the management of inflammatory bowel disease.
    J Gastroenterol. 2016.
    PubMed     Text format     Abstract available


    January 2016
  19. BETTENWORTH D, Lopez R, Hindryckx P, Levesque BG, et al
    Heterogeneity in endoscopic treatment of Crohn's disease-associated strictures: An international inflammatory bowel disease specialist survey.
    J Gastroenterol. 2016.
    PubMed     Text format     Abstract available


    November 2015
  20. ASADA A, Nishida A, Shioya M, Imaeda H, et al
    NUDT15 R139C-related thiopurine leukocytopenia is mediated by 6-thioguanine nucleotide-independent mechanism in Japanese patients with inflammatory bowel disease.
    J Gastroenterol. 2015.
    PubMed     Text format     Abstract available


    October 2015
  21. FUYUNO Y, Yamazaki K, Takahashi A, Esaki M, et al
    Genetic characteristics of inflammatory bowel disease in a Japanese population.
    J Gastroenterol. 2015.
    PubMed     Text format     Abstract available


    July 2015
  22. KOBAYASHI T, Suzuki Y, Motoya S, Hirai F, et al
    First trough level of infliximab at week 2 predicts future outcomes of induction therapy in ulcerative colitis-results from a multicenter prospective randomized controlled trial and its post hoc analysis.
    J Gastroenterol. 2015.
    PubMed     Text format     Abstract available


  23. OKAMOTO R, Watanabe M
    Role of epithelial cells in the pathogenesis and treatment of inflammatory bowel disease.
    J Gastroenterol. 2015.
    PubMed     Text format     Abstract available


    May 2015
  24. NIIKURA R, Yasunaga H, Yamaji Y, Horiguchi H, et al
    Factors affecting in-hospital mortality in patients with lower gastrointestinal tract bleeding: a retrospective study using a national database in Japan.
    J Gastroenterol. 2015;50:533-40.
    PubMed     Text format     Abstract available


    April 2015
  25. KAWAGUCHI T, Mori M, Saito K, Suga Y, et al
    Food antigen-induced immune responses in Crohn's disease patients and experimental colitis mice.
    J Gastroenterol. 2015;50:394-405.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Inflammatory Bowel Diseases is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: